DreamCIS, Inc. (KOSDAQ: 223250)

Market Cap	86.75B
Revenue (ttm)	53.12B
Net Income (ttm)	3.82B
Shares Out	23.80M
EPS (ttm)	157.87
PE Ratio	23.09
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	89,245
Open	3,565.00
Previous Close	3,595.00
Day's Range	3,520.00 - 3,700.00
52-Week Range	2,610.00 - 30,650.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DreamCIS

DreamCIS, Inc. provides clinical research services in South Korea. It offers clinical development services; biostatic, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services. The company was founded in 2000 and is headquartered in Seoul, South Korea.

• Industry: Commercial Physical and Biological Research
• Founded: 2000
• Employees: 236
• Stock Exchange: KOSDAQ
• Ticker Symbol: 223250

Financial Performance

In 2023, DreamCIS's revenue was 47.84 billion, an increase of 23.08% compared to the previous year's 38.87 billion. Earnings were 3.74 billion, a decrease of -15.13%.